Major owner of Pernix Therapeutics Holdings just sold 1,250,000 shares

Cooper C. Collins, a major owner of Pernix Therapeutics Holdings and Pernix Therapeutics Holdings's Chief Strategic Officer and a director of the company, recently sold 1,250,000 shares of the company. The sales took place at $4.04 per share, on July 24, 2013. Collins still owns 7,656,571 shares of the company. Collins operates out of Magnolia, TX.

The above information was disclosed in a filing to the SEC. Some additional info was provided as follows:

The Reporting Person sold these shares in a private placement to a third party in exchange for a minority interest in a privately-held investment company. The value placed on the shares in this transaction was $4.04 per share (the closing price per share on NASDAQ on the date of the transaction). As of the dat e of the sale, the Reporting Person does not have any investment control over these shares. However, Mr. Collins retains all voting rights in these shares for a period of six months following the transaction.

To see this filing in its entirety, click here. Pernix Therapeutics Holdings next reports earnings on August 12, 2013.

To receive a free e-mail notification whenever an insider of Pernix Therapeutics Holdings makes a similar move, sign up!

   Auto Refresh